Clinical Ophthalmic Oncology
Springer International Publishing (Verlag)
978-3-031-77176-7 (ISBN)
- Noch nicht erschienen - erscheint am 12.02.2025
- Versandkostenfrei innerhalb Deutschlands
- Auch auf Rechnung
- Verfügbarkeit in der Filiale vor Ort prüfen
- Artikel merken
Written by internationally renowned experts, this book is the newest volume in the Clinical Ophthalmic Oncology book series. This book, in addition to the other six volumes provides detailed practical guidance and advice on the diagnosis and management of the complete range of ocular cancers. Supplying the reader with state-of-the-art knowledge required in order to identify these cancers early and to treat them as effectively as possible, this book covers Retinoblastoma. The information presented enables readers to provide effective patient care using the latest knowledge on ophthalmic oncology and to verify diagnostic conclusions based on comparison with numerous full-color clinical photographs from the authors' private collections, histopathologic microphotographs, imaging studies, and crisp illustrations.
Clinical Ophthalmic Oncology's clinically focused and user-friendly format allows for rapid retrieval of information in daily practice and is written for residents, fellows, and any physician involved in the care of patients with ocular or orbital malignancies. Additionally, this edition adds several hundred new images to improve comprehension of procedures and techniques. This volume describes the classification, differential diagnosis, and imaging of retinoblastoma and discusses the most suitable treatment options for different tumor types.
Jesse L. Berry, MD, received her undergraduate and medical degree from Harvard University in Massachusetts. Following her ophthalmology residency at the University of Southern California, she was the assistant chief of service at the Los Angeles County Medical Center and then completed a fellowship in Ocular Oncology at Children's Hospital Los Angeles. Dr. Berry is the founder of WOO, Women in Ocular Oncology.
Bertil Damato, MD, PhD, is Professor of Ophthalmology and Radiation Oncology and Director of the Ocular Oncology Service at the University of California, San Francisco. Until 2013, he was Consultant Ophthalmologist at the Royal Liverpool University Hospital, where he was Director of the Ocular Oncology Service, which he established in 1993. Dr. Damato has published more than 200 peer-reviewed articles, 68 reviews, 75 book chapters and 6 books, one as single author.
Arun Singh, MD, is Director of the Cole Eye Institute at Cleveland Clinic in the Department of Ophthalmic Oncology. He is also the Series Editor for Springer's Essentials in Ophthalmology series and was the former Editor for The British Journal of Ophthalmology and is the current Editor of Ocular Oncology and Pathology.
Chapter 1. Retinoblastoma: Evaluation and Diagnosis.- Chapter 2. Differential Diagnosis of Leukocoria.- Chapter 3. Retinoblastoma: Staging and Grouping.- Chapter 4. Retinoblastoma: Incidence and Etiologic Factors.- Chapter 5. Retinoblastoma: Global Burden.- Chapter 6. Retinoblastoma: Global Initiatives.- Chapter 7. Retinoblastoma Tumorigenesis.- Chapter 8. Retinoblastoma: Evolving Role of Molecular Analysis and Subtypes.- Chapter 9. Animal Models in Retinoblastoma Research.- Chapter 10. Retinocytoma or Retinoma.- Chapter 11. Retinoblastoma: Genetic Counseling and Testing.- Chapter 12. Retinoblastoma: Evolution of Treatment Methods.- Chapter 13. Retinoblastoma: Treatment Options.- Chapter 14. Retinoblastoma: Laser Treatment and Cryotherapy.- Chapter 15. Retinoblastoma: Brachytherapy.- Chapter 16. Retinoblastoma: Intravenous Chemotherapy.- Chapter 17. Retinoblastoma: Intra-ophthalmic Artery Chemotherapy.- Chapter 18. Retinoblastoma: Intravitreal / Intracameral Chemotherapy.- Chapter 19. Retinoblastoma: External beam radiation.- Chapter 20. Retinoblastoma: Enucleation.- Chapter 21. Retinoblastoma: Emerging Surgical Techniques.- Chapter 22. Retinoblastoma: Emerging Medical Techniques.- Chapter 23. Histopathologic Features and Prognostic Factors.- Chapter 24. Retinoblastoma: Aqueous Biomarkers.- Chapter 25. Retinoblastoma: Blood Biomarkers.- Chapter 26. Orbital Retinoblastoma: Diagnosis and Management.- Chapter 27. Retinoblastoma: Metastatic Disease.- Chapter 28. Retinoblastoma: Non ocular tumors and other long term complications.- Chapter 29. Trilateral Retinoblastoma.- Chapter 30. Screening Children at Risk for Retinoblastoma.- Chapter 31. Children's Oncology Group (COG) Trials for Retinoblastoma.- Chapter 32. Social Aspects, Advocacy and Organizations.
| Erscheint lt. Verlag | 12.2.2025 |
|---|---|
| Zusatzinfo | Approx. 500 p. 100 illus. in color. |
| Verlagsort | Cham |
| Sprache | englisch |
| Maße | 210 x 279 mm |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Augenheilkunde |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
| Schlagworte | Brachytherapy • Cancer Staging • clinical ophthalmic oncology • complications • enucleation • immunology • Intravenous Chemotherapy • Intravitreal/ Intracameral Chemotherapy • reinoblastoma • Retinocytoma • targeted therapy • Tumor Associated Diseases • Tumorigenesis |
| ISBN-10 | 3-031-77176-1 / 3031771761 |
| ISBN-13 | 978-3-031-77176-7 / 9783031771767 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
